THE INTIMATE LIFESPAN

From puberty to menopause, women’s intimate health changes throughout life, requiring informed, evidence-based care.

Vaginal health has long been surrounded by silence, discomfort and misunderstanding. Across many cultures, conversations about intimate health have historically been considered inappropriate or embarrassing, creating a stigma that has discouraged open discussion and education. Although this stigma still exists in the UK and many parts of the world, growing awareness of women’s intimate health, alongside increased media attention and the rising popularity of vaginal rejuvenation procedures, has encouraged more open conversations than ever before.

This shift is important because vaginal concerns are not confined to one stage of life. Women experience a wide range of intimate health concerns throughout adolescence, adulthood and later life. While some conditions can occur at any age, others are closely linked to hormonal changes, pregnancy, childbirth or menopause.

Many vaginal concerns are common and highly treatable, yet embarrassment continues to prevent women from seeking timely advice. This is particularly true for conditions that cause changes in discharge, odour or sensation, where fears of judgement or assumptions about poor hygiene can discourage women from speaking to a healthcare professional. Although these symptoms can be distressing, they are rarely serious when recognised and managed appropriately.

COMMON VAGINAL HEALTH CONCERNS

Two of the most common vaginal conditions are bacterial vaginosis (BV) and vulvovaginal candidiasis (thrush). Although they share some symptoms, they have different underlying causes and require different treatment approaches.

BV can affect women of all ages after puberty but is most common during the reproductive years. The vaginal microbiome is normally dominated by beneficial bacteria that help maintain a slightly acidic pH. In BV, this balance is disrupted, allowing other bacteria to proliferate. The precise cause of this imbalance remains unclear, which can make recurrent episodes particularly frustrating for those affected.

Several factors have been associated with an increased likelihood of developing BV, including having a new sexual partner or multiple partners, smoking, vaginal douching and the use of scented intimate hygiene products. While sexual activity can influence the vaginal microbiome, it is important to note that BV is not classified as a sexually transmitted infection.

Thrush is another common condition that women frequently confuse with BV. Typical symptoms include intense itching, soreness, redness and a thick, white vaginal discharge. Unlike BV, thrush does not usually produce a strong or unpleasant odour, although the irritation it causes can be significant.

Thrush results from an overgrowth of Candida, a yeast that naturally exists within the body. This overgrowth occurs when changes to the vaginal environment favour yeast proliferation. Although thrush can affect women at any age, it is most common during the reproductive years when higher oestrogen levels create a more favourable environment for yeast growth. It is less common before puberty and after menopause, although it may still occur following antibiotic use, poorly controlled diabetes or other factors that disrupt the vaginal microbiome or immune system.

APPEARANCE VERSUS ANATOMY

While many intimate concerns relate to physical health, women may also experience worries about the appearance of their genital anatomy. In reality, these concerns more commonly relate to the vulva – which includes the labia and surrounding external structures – rather than the internal vaginal canal.

As girls progress through puberty and become more aware of their changing bodies, self-consciousness about appearance often begins to develop. This awareness is increasingly influenced by media portrayals and online imagery that promote a narrow and often unrealistic representation of female anatomy.

It is important to recognise that there is considerable natural variation in vulval appearance. Differences in size, shape, colour and symmetry are entirely normal. Nevertheless, some women experience genuine distress or reduced confidence about their appearance, particularly within intimate relationships. For these patients, reassurance, education and realistic expectations remain an important part of any consultation.

PREGNANCY, CHILDBIRTH AND AGEING

For many women, pregnancy and childbirth bring both functional and anatomical changes. Vaginal delivery places considerable strain on the pelvic floor muscles and surrounding tissues. During the months that follow, some women notice vaginal laxity, reduced muscle tone, dryness or discomfort during sexual intercourse. Others may experience altered sensation or mild symptoms of pelvic organ prolapse.

Although many postpartum changes improve naturally, particularly when supported by pelvic floor rehabilitation, some symptoms may persist and continue to affect quality of life.

Independent of childbirth, the natural ageing process also contributes to changes in vaginal tissue quality. As oestrogen levels gradually decline, the elasticity and resilience of the vaginal walls reduce. Tissues that were once firm and supple may become thinner and less elastic, sometimes contributing to a sensation of vaginal looseness. These changes may influence comfort, sexual wellbeing and, in some cases, the support of surrounding pelvic organs.

MENOPAUSE AND VAGINAL HEALTH

Perimenopause and menopause introduce further changes to the vaginal tissues as declining oestrogen levels reduce natural lubrication. For many women, this leads to dryness, itching, irritation and discomfort during sexual intercourse, with symptoms often developing gradually before becoming more pronounced after menopause.

Early recognition and appropriate management can therefore have a significant impact on quality of life.

Vaginal dryness is more than a minor inconvenience. Reduced lubrication can affect comfort, intimacy and everyday activities, while thinner, more fragile tissues become increasingly susceptible to irritation, inflammation and minor injury.

For many women, simple measures such as over-the-counter vaginal moisturisers and lubricants provide effective symptom relief.

In other cases, prescription treatment may be appropriate. Local oestrogen therapy, available as creams, pessaries or vaginal rings, can help restore tissue hydration and improve long-term comfort for women experiencing symptoms associated with declining oestrogen levels.

EXPLORING AESTHETIC TREATMENT OPTIONS

Alongside established medical management, a range of aesthetic interventions is now available for women seeking to address both functional and appearance-related concerns.

Surgical procedures, such as labiaplasty and vaginoplasty, may be appropriate for carefully selected patients experiencing significant functional concerns or dissatisfaction with vulval appearance. These procedures can provide lasting anatomical changes but require appropriate counselling regarding recovery, potential complications and expected outcomes.

For women seeking less invasive options, non-surgical treatments have grown in popularity in recent years. These include energy-based devices, such as laser and radiofrequency technologies, alongside regenerative treatments designed to improve tissue quality. Although these approaches continue to evolve, treatment should always be based on careful patient assessment and current evidence. Laser therapies, including fractional CO2 and Er:YAG devices, use controlled thermal energy to stimulate tissue remodelling. Applied to the vaginal canal, these treatments aim to promote collagen production and improve tissue quality, which may help alleviate symptoms such as mild vaginal laxity and dryness in appropriately selected patients. Some treatment protocols also include the external vulva, with the goal of improving skin texture and overall tissue quality.

Radiofrequency technologies work in a similar way by delivering controlled heat into deeper tissue layers to encourage collagen remodelling and improve local blood flow. Devices such as EmFemme 360 (BTL) and FormaV (InMode) are used by some practitioners to address concerns including vaginal laxity, lubrication and vulval tissue quality. Results are typically gradual and generally more modest than those achieved with surgery, with maintenance treatments often recommended.

Regenerative therapies have also attracted increasing interest within intimate health. Platelet-rich plasma (PRP), prepared from the patient’s own blood, has been investigated for its potential to support tissue repair and stimulate collagen production. Some practitioners use PRP to address symptoms including vaginal dryness and reduced tissue quality, although the evidence base remains limited and continues to develop.

Polynucleotide-based injectables represent another emerging area of regenerative medicine. Already established in facial aesthetics, they are increasingly being explored for improving the quality, hydration and resilience of external vulval tissue. However, published evidence supporting their use in intimate health remains limited, and further research is needed to establish long-term efficacy and safety.

As with any aesthetic procedure, patient selection, informed consent and realistic expectation setting remain essential. Women considering treatment should be fully informed about the available evidence, expected outcomes, potential risks and alternative management options before proceeding.

SUPPORTING WOMEN’S INTIMATE HEALTH

Although many of these concerns are common, they remain under-discussed. Encouraging open, evidence-based conversations can help reduce stigma and empower women to seek advice sooner when symptoms affect their health or wellbeing.

Equally important is recognising that there is no single ‘ideal’ vulval or vaginal appearance. Normal anatomical variation is considerable, and aesthetic concerns should always be approached with sensitivity and appropriate counselling.

For women who choose to explore treatment options, advances in both medical and aesthetic care continue to expand the range of available interventions. By ensuring patients receive balanced information and appropriate clinical guidance, practitioners can support informed decision-making and help women make choices that are right for their individual needs.

DAWN ATTEWELL

Dawn Attewell is an award-winning aesthetic nurse and Independent Nurse Prescriber, specialising in injectable treatments, medical devices and hormonal health. She has helped countless women navigate the cosmetic and health-related changes associated with natural ageing and menopause, supporting them to improve their skin health, vaginal health and hormonal balance. Dawn established Therapy House, of which Dawn Attewell Aesthetics is the cosmetic medical off-shoot, and has built a reputation for clinical excellence and patient safety.